nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—DHFR—Pemetrexed—lung cancer	0.584	0.696	CbGbCtD
Pyrimethamine—DHFR—Methotrexate—lung cancer	0.0991	0.118	CbGbCtD
Pyrimethamine—CYP2C9—Gefitinib—lung cancer	0.0193	0.0231	CbGbCtD
Pyrimethamine—CYP2C9—Teniposide—lung cancer	0.0188	0.0224	CbGbCtD
Pyrimethamine—CYP2D6—Gefitinib—lung cancer	0.0177	0.0211	CbGbCtD
Pyrimethamine—CYP2C8—Erlotinib—lung cancer	0.0164	0.0196	CbGbCtD
Pyrimethamine—CYP2C8—Paclitaxel—lung cancer	0.015	0.0179	CbGbCtD
Pyrimethamine—CYP2D6—Vinorelbine—lung cancer	0.0136	0.0163	CbGbCtD
Pyrimethamine—CYP2C8—Etoposide—lung cancer	0.0119	0.0141	CbGbCtD
Pyrimethamine—CYP2C9—Paclitaxel—lung cancer	0.0105	0.0125	CbGbCtD
Pyrimethamine—CYP2D6—Erlotinib—lung cancer	0.0105	0.0125	CbGbCtD
Pyrimethamine—CYP2C9—Cisplatin—lung cancer	0.00842	0.01	CbGbCtD
Pyrimethamine—CYP2D6—Vinblastine—lung cancer	0.00839	0.01	CbGbCtD
Pyrimethamine—CYP2D6—Doxorubicin—lung cancer	0.00516	0.00615	CbGbCtD
Pyrimethamine—Anaemia megaloblastic—Methotrexate—lung cancer	0.00242	0.0307	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Pemetrexed—lung cancer	0.00177	0.0224	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Gefitinib—lung cancer	0.00176	0.0223	CcSEcCtD
Pyrimethamine—Pancytopenia—Pemetrexed—lung cancer	0.00161	0.0204	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Pemetrexed—lung cancer	0.0015	0.019	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Gefitinib—lung cancer	0.00149	0.0189	CcSEcCtD
Pyrimethamine—Haematuria—Gefitinib—lung cancer	0.00143	0.0182	CcSEcCtD
Pyrimethamine—Pancytopenia—Teniposide—lung cancer	0.00131	0.0165	CcSEcCtD
Pyrimethamine—Erythema multiforme—Pemetrexed—lung cancer	0.00129	0.0163	CcSEcCtD
Pyrimethamine—Erythema multiforme—Gefitinib—lung cancer	0.00128	0.0162	CcSEcCtD
Pyrimethamine—Leukopenia—Crizotinib—lung cancer	0.00116	0.0147	CcSEcCtD
Pyrimethamine—Leukopenia—Pemetrexed—lung cancer	0.00106	0.0134	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Erlotinib—lung cancer	0.00105	0.0133	CcSEcCtD
Pyrimethamine—Pancytopenia—Vinblastine—lung cancer	0.000997	0.0126	CcSEcCtD
Pyrimethamine—Pancytopenia—Topotecan—lung cancer	0.000968	0.0123	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Pemetrexed—lung cancer	0.000966	0.0122	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Pemetrexed—lung cancer	0.000945	0.012	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Gefitinib—lung cancer	0.000939	0.0119	CcSEcCtD
Pyrimethamine—Anorexia—Pemetrexed—lung cancer	0.00092	0.0117	CcSEcCtD
Pyrimethamine—Decreased appetite—Crizotinib—lung cancer	0.000919	0.0116	CcSEcCtD
Pyrimethamine—Anorexia—Gefitinib—lung cancer	0.000915	0.0116	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Erlotinib—lung cancer	0.000892	0.0113	CcSEcCtD
Pyrimethamine—Leukopenia—Teniposide—lung cancer	0.000858	0.0109	CcSEcCtD
Pyrimethamine—Decreased appetite—Pemetrexed—lung cancer	0.000839	0.0106	CcSEcCtD
Pyrimethamine—Decreased appetite—Gefitinib—lung cancer	0.000834	0.0106	CcSEcCtD
Pyrimethamine—Pancytopenia—Vinorelbine—lung cancer	0.000828	0.0105	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Teniposide—lung cancer	0.000766	0.00969	CcSEcCtD
Pyrimethamine—Erythema multiforme—Erlotinib—lung cancer	0.000763	0.00966	CcSEcCtD
Pyrimethamine—Anorexia—Teniposide—lung cancer	0.000746	0.00944	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Gemcitabine—lung cancer	0.00073	0.00924	CcSEcCtD
Pyrimethamine—Hypersensitivity—Pemetrexed—lung cancer	0.000711	0.00901	CcSEcCtD
Pyrimethamine—Hypersensitivity—Gefitinib—lung cancer	0.000707	0.00895	CcSEcCtD
Pyrimethamine—Decreased appetite—Teniposide—lung cancer	0.00068	0.00861	CcSEcCtD
Pyrimethamine—Vomiting—Crizotinib—lung cancer	0.000672	0.0085	CcSEcCtD
Pyrimethamine—Pancytopenia—Gemcitabine—lung cancer	0.000665	0.00842	CcSEcCtD
Pyrimethamine—Leukopenia—Vinblastine—lung cancer	0.000655	0.00829	CcSEcCtD
Pyrimethamine—Leukopenia—Topotecan—lung cancer	0.000636	0.00805	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Etoposide—lung cancer	0.000623	0.00789	CcSEcCtD
Pyrimethamine—Pancytopenia—Cisplatin—lung cancer	0.00062	0.00785	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Gemcitabine—lung cancer	0.000619	0.00784	CcSEcCtD
Pyrimethamine—Vomiting—Pemetrexed—lung cancer	0.000614	0.00777	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Paclitaxel—lung cancer	0.000611	0.00774	CcSEcCtD
Pyrimethamine—Vomiting—Gefitinib—lung cancer	0.00061	0.00772	CcSEcCtD
Pyrimethamine—Haematuria—Gemcitabine—lung cancer	0.000596	0.00754	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Vinblastine—lung cancer	0.000584	0.0074	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Topotecan—lung cancer	0.00058	0.00734	CcSEcCtD
Pyrimethamine—Hypersensitivity—Teniposide—lung cancer	0.000576	0.00729	CcSEcCtD
Pyrimethamine—Anorexia—Vinblastine—lung cancer	0.000569	0.0072	CcSEcCtD
Pyrimethamine—Pancytopenia—Etoposide—lung cancer	0.000568	0.00719	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Topotecan—lung cancer	0.000568	0.00719	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Erlotinib—lung cancer	0.000562	0.00711	CcSEcCtD
Pyrimethamine—Pancytopenia—Paclitaxel—lung cancer	0.000557	0.00705	CcSEcCtD
Pyrimethamine—Anorexia—Topotecan—lung cancer	0.000553	0.007	CcSEcCtD
Pyrimethamine—Anorexia—Erlotinib—lung cancer	0.000547	0.00692	CcSEcCtD
Pyrimethamine—Leukopenia—Vinorelbine—lung cancer	0.000544	0.00689	CcSEcCtD
Pyrimethamine—Erythema multiforme—Gemcitabine—lung cancer	0.00053	0.00671	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Etoposide—lung cancer	0.000529	0.00669	CcSEcCtD
Pyrimethamine—Lamotrigine—ABCB1—lung cancer	0.000523	1	CrCbGaD
Pyrimethamine—Decreased appetite—Vinblastine—lung cancer	0.000519	0.00657	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Paclitaxel—lung cancer	0.000519	0.00656	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Docetaxel—lung cancer	0.000518	0.00656	CcSEcCtD
Pyrimethamine—Decreased appetite—Topotecan—lung cancer	0.000504	0.00638	CcSEcCtD
Pyrimethamine—Haematuria—Paclitaxel—lung cancer	0.000499	0.00631	CcSEcCtD
Pyrimethamine—Decreased appetite—Erlotinib—lung cancer	0.000499	0.00631	CcSEcCtD
Pyrimethamine—Vomiting—Teniposide—lung cancer	0.000497	0.0063	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Vinorelbine—lung cancer	0.000496	0.00628	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Vinorelbine—lung cancer	0.000486	0.00615	CcSEcCtD
Pyrimethamine—Anorexia—Vinorelbine—lung cancer	0.000473	0.00598	CcSEcCtD
Pyrimethamine—Pancytopenia—Docetaxel—lung cancer	0.000472	0.00598	CcSEcCtD
Pyrimethamine—Erythema multiforme—Etoposide—lung cancer	0.000453	0.00573	CcSEcCtD
Pyrimethamine—Leukopenia—Irinotecan—lung cancer	0.000449	0.00568	CcSEcCtD
Pyrimethamine—Erythema multiforme—Paclitaxel—lung cancer	0.000444	0.00562	CcSEcCtD
Pyrimethamine—Hypersensitivity—Vinblastine—lung cancer	0.00044	0.00557	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.00044	0.00556	CcSEcCtD
Pyrimethamine—Leukopenia—Gemcitabine—lung cancer	0.000437	0.00553	CcSEcCtD
Pyrimethamine—Decreased appetite—Vinorelbine—lung cancer	0.000431	0.00546	CcSEcCtD
Pyrimethamine—Hypersensitivity—Topotecan—lung cancer	0.000427	0.00541	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Irinotecan—lung cancer	0.000409	0.00518	CcSEcCtD
Pyrimethamine—Leukopenia—Cisplatin—lung cancer	0.000407	0.00516	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Irinotecan—lung cancer	0.0004	0.00507	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Gemcitabine—lung cancer	0.000398	0.00504	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Gemcitabine—lung cancer	0.00039	0.00494	CcSEcCtD
Pyrimethamine—Anorexia—Irinotecan—lung cancer	0.00039	0.00494	CcSEcCtD
Pyrimethamine—Anorexia—Gemcitabine—lung cancer	0.00038	0.00481	CcSEcCtD
Pyrimethamine—Vomiting—Vinblastine—lung cancer	0.000379	0.0048	CcSEcCtD
Pyrimethamine—Erythema multiforme—Docetaxel—lung cancer	0.000376	0.00476	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000373	0.00473	CcSEcCtD
Pyrimethamine—Leukopenia—Etoposide—lung cancer	0.000373	0.00472	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Cisplatin—lung cancer	0.000371	0.0047	CcSEcCtD
Pyrimethamine—Vomiting—Topotecan—lung cancer	0.000369	0.00467	CcSEcCtD
Pyrimethamine—Leukopenia—Paclitaxel—lung cancer	0.000366	0.00463	CcSEcCtD
Pyrimethamine—Hypersensitivity—Vinorelbine—lung cancer	0.000365	0.00463	CcSEcCtD
Pyrimethamine—Vomiting—Erlotinib—lung cancer	0.000365	0.00462	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Cisplatin—lung cancer	0.000364	0.0046	CcSEcCtD
Pyrimethamine—Decreased appetite—Irinotecan—lung cancer	0.000356	0.0045	CcSEcCtD
Pyrimethamine—Anorexia—Cisplatin—lung cancer	0.000354	0.00448	CcSEcCtD
Pyrimethamine—Decreased appetite—Gemcitabine—lung cancer	0.000346	0.00438	CcSEcCtD
Pyrimethamine—Pancytopenia—Methotrexate—lung cancer	0.00034	0.00431	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Etoposide—lung cancer	0.00034	0.00431	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Paclitaxel—lung cancer	0.000334	0.00422	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Etoposide—lung cancer	0.000333	0.00422	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Paclitaxel—lung cancer	0.000327	0.00413	CcSEcCtD
Pyrimethamine—Anorexia—Etoposide—lung cancer	0.000324	0.0041	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000323	0.00409	CcSEcCtD
Pyrimethamine—Decreased appetite—Cisplatin—lung cancer	0.000323	0.00409	CcSEcCtD
Pyrimethamine—Anorexia—Paclitaxel—lung cancer	0.000318	0.00402	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000317	0.00401	CcSEcCtD
Pyrimethamine—Vomiting—Vinorelbine—lung cancer	0.000315	0.00399	CcSEcCtD
Pyrimethamine—Leukopenia—Docetaxel—lung cancer	0.00031	0.00393	CcSEcCtD
Pyrimethamine—Haematuria—Methotrexate—lung cancer	0.000305	0.00386	CcSEcCtD
Pyrimethamine—Hypersensitivity—Irinotecan—lung cancer	0.000301	0.00381	CcSEcCtD
Pyrimethamine—Decreased appetite—Etoposide—lung cancer	0.000296	0.00374	CcSEcCtD
Pyrimethamine—Pancytopenia—Doxorubicin—lung cancer	0.000295	0.00373	CcSEcCtD
Pyrimethamine—Decreased appetite—Paclitaxel—lung cancer	0.00029	0.00367	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Docetaxel—lung cancer	0.000283	0.00358	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Docetaxel—lung cancer	0.000277	0.0035	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000274	0.00347	CcSEcCtD
Pyrimethamine—Hypersensitivity—Cisplatin—lung cancer	0.000274	0.00346	CcSEcCtD
Pyrimethamine—Erythema multiforme—Methotrexate—lung cancer	0.000271	0.00343	CcSEcCtD
Pyrimethamine—Anorexia—Docetaxel—lung cancer	0.00027	0.00341	CcSEcCtD
Pyrimethamine—Haematuria—Doxorubicin—lung cancer	0.000264	0.00334	CcSEcCtD
Pyrimethamine—Vomiting—Irinotecan—lung cancer	0.00026	0.00329	CcSEcCtD
Pyrimethamine—Vomiting—Gemcitabine—lung cancer	0.000253	0.00321	CcSEcCtD
Pyrimethamine—Hypersensitivity—Etoposide—lung cancer	0.000251	0.00317	CcSEcCtD
Pyrimethamine—Decreased appetite—Docetaxel—lung cancer	0.000246	0.00311	CcSEcCtD
Pyrimethamine—Hypersensitivity—Paclitaxel—lung cancer	0.000246	0.00311	CcSEcCtD
Pyrimethamine—Vomiting—Cisplatin—lung cancer	0.000236	0.00299	CcSEcCtD
Pyrimethamine—Erythema multiforme—Doxorubicin—lung cancer	0.000235	0.00297	CcSEcCtD
Pyrimethamine—Leukopenia—Methotrexate—lung cancer	0.000224	0.00283	CcSEcCtD
Pyrimethamine—Vomiting—Etoposide—lung cancer	0.000216	0.00274	CcSEcCtD
Pyrimethamine—Vomiting—Paclitaxel—lung cancer	0.000212	0.00268	CcSEcCtD
Pyrimethamine—Hypersensitivity—Docetaxel—lung cancer	0.000208	0.00264	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Methotrexate—lung cancer	0.000204	0.00258	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Methotrexate—lung cancer	0.0002	0.00253	CcSEcCtD
Pyrimethamine—Anorexia—Methotrexate—lung cancer	0.000194	0.00246	CcSEcCtD
Pyrimethamine—Leukopenia—Doxorubicin—lung cancer	0.000194	0.00245	CcSEcCtD
Pyrimethamine—Vomiting—Docetaxel—lung cancer	0.00018	0.00228	CcSEcCtD
Pyrimethamine—Decreased appetite—Methotrexate—lung cancer	0.000177	0.00224	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Doxorubicin—lung cancer	0.000176	0.00223	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Doxorubicin—lung cancer	0.000173	0.00219	CcSEcCtD
Pyrimethamine—Anorexia—Doxorubicin—lung cancer	0.000168	0.00213	CcSEcCtD
Pyrimethamine—Decreased appetite—Doxorubicin—lung cancer	0.000153	0.00194	CcSEcCtD
Pyrimethamine—Hypersensitivity—Methotrexate—lung cancer	0.00015	0.0019	CcSEcCtD
Pyrimethamine—Hypersensitivity—Doxorubicin—lung cancer	0.00013	0.00165	CcSEcCtD
Pyrimethamine—Vomiting—Methotrexate—lung cancer	0.00013	0.00164	CcSEcCtD
Pyrimethamine—Vomiting—Doxorubicin—lung cancer	0.000112	0.00142	CcSEcCtD
Pyrimethamine—DHFR—Cell Cycle—CDKN1A—lung cancer	3.63e-05	0.000441	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	3.62e-05	0.00044	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PLBD1—lung cancer	3.62e-05	0.000439	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.56e-05	0.000432	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ERCC2—lung cancer	3.55e-05	0.000432	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	3.51e-05	0.000426	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ERBB3—lung cancer	3.48e-05	0.000422	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—MAPK3—lung cancer	3.46e-05	0.00042	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—EP300—lung cancer	3.46e-05	0.00042	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTP1—lung cancer	3.45e-05	0.000418	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—MYC—lung cancer	3.37e-05	0.000409	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CAT—lung cancer	3.35e-05	0.000407	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TERT—lung cancer	3.33e-05	0.000405	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ATP5H—lung cancer	3.33e-05	0.000404	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—POMC—lung cancer	3.32e-05	0.000403	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HSD17B10—lung cancer	3.31e-05	0.000402	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ATP5H—lung cancer	3.3e-05	0.000401	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—POMC—lung cancer	3.29e-05	0.0004	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ABCB1—lung cancer	3.26e-05	0.000396	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—FGFR1—lung cancer	3.24e-05	0.000393	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—TYMS—lung cancer	3.2e-05	0.000389	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HIF1A—lung cancer	3.19e-05	0.000387	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTM1—lung cancer	3.17e-05	0.000384	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—MAPK3—lung cancer	3.1e-05	0.000376	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—APOA1—lung cancer	3.07e-05	0.000373	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CKB—lung cancer	3.07e-05	0.000373	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.03e-05	0.000368	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—MYC—lung cancer	3.01e-05	0.000366	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CYP1A1—lung cancer	3e-05	0.000364	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ERCC2—lung cancer	2.98e-05	0.000361	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PLBD1—lung cancer	2.97e-05	0.00036	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PLBD1—lung cancer	2.94e-05	0.000357	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.89e-05	0.000351	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTM2—lung cancer	2.89e-05	0.000351	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CNDP2—lung cancer	2.89e-05	0.000351	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTMR3—lung cancer	2.81e-05	0.000341	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—KIT—lung cancer	2.81e-05	0.000341	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—APC—lung cancer	2.81e-05	0.000341	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—EGF—lung cancer	2.77e-05	0.000337	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PGAM1—lung cancer	2.74e-05	0.000333	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HSD17B10—lung cancer	2.71e-05	0.00033	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HSD17B10—lung cancer	2.69e-05	0.000327	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—BRAF—lung cancer	2.64e-05	0.00032	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2A7—lung cancer	2.61e-05	0.000317	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6R—lung cancer	2.61e-05	0.000317	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CREBBP—lung cancer	2.6e-05	0.000316	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—APOA1—lung cancer	2.58e-05	0.000313	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SDC4—lung cancer	2.56e-05	0.000311	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CKB—lung cancer	2.52e-05	0.000306	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CKB—lung cancer	2.5e-05	0.000304	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MAP2K1—lung cancer	2.48e-05	0.000302	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—TP53—lung cancer	2.47e-05	0.0003	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CD—lung cancer	2.47e-05	0.0003	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTM2—lung cancer	2.37e-05	0.000288	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CNDP2—lung cancer	2.37e-05	0.000288	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CNDP2—lung cancer	2.35e-05	0.000286	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTM2—lung cancer	2.35e-05	0.000286	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CG—lung cancer	2.35e-05	0.000285	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—RRM1—lung cancer	2.33e-05	0.000283	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTA3—lung cancer	2.33e-05	0.000283	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTMR3—lung cancer	2.31e-05	0.00028	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTMR3—lung cancer	2.29e-05	0.000278	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PGAM1—lung cancer	2.25e-05	0.000273	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—POMC—lung cancer	2.24e-05	0.000272	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PGAM1—lung cancer	2.23e-05	0.000271	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MDM2—lung cancer	2.21e-05	0.000268	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—RAF1—lung cancer	2.2e-05	0.000268	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—B4GALT5—lung cancer	2.19e-05	0.000266	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CREBBP—lung cancer	2.18e-05	0.000265	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ERBB2—lung cancer	2.18e-05	0.000265	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CB—lung cancer	2.15e-05	0.000261	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MTOR—lung cancer	2.15e-05	0.000261	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CD4—lung cancer	2.15e-05	0.000261	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP2A7—lung cancer	2.15e-05	0.000261	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTGS2—lung cancer	2.13e-05	0.000259	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTA4—lung cancer	2.13e-05	0.000259	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2A7—lung cancer	2.13e-05	0.000258	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SDC4—lung cancer	2.1e-05	0.000255	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.08e-05	0.000253	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SDC4—lung cancer	2.08e-05	0.000253	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTA2—lung cancer	2.08e-05	0.000252	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CD—lung cancer	2.07e-05	0.000251	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ALB—lung cancer	2.04e-05	0.000248	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTA1—lung cancer	2e-05	0.000243	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCC3—lung cancer	1.98e-05	0.000241	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AKR1C1—lung cancer	1.92e-05	0.000233	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA3—lung cancer	1.91e-05	0.000232	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—RRM1—lung cancer	1.91e-05	0.000232	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—RRM1—lung cancer	1.9e-05	0.00023	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA3—lung cancer	1.9e-05	0.00023	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CDKN1A—lung cancer	1.86e-05	0.000226	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—UGT1A1—lung cancer	1.86e-05	0.000226	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTEN—lung cancer	1.86e-05	0.000226	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CB—lung cancer	1.8e-05	0.000219	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—B4GALT5—lung cancer	1.8e-05	0.000218	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GNG11—lung cancer	1.8e-05	0.000218	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.79e-05	0.000217	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTGS2—lung cancer	1.78e-05	0.000217	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—B4GALT5—lung cancer	1.78e-05	0.000216	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—EP300—lung cancer	1.77e-05	0.000215	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA4—lung cancer	1.75e-05	0.000212	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA4—lung cancer	1.73e-05	0.000211	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SRC—lung cancer	1.72e-05	0.000209	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALDOA—lung cancer	1.71e-05	0.000208	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA2—lung cancer	1.7e-05	0.000207	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.7e-05	0.000206	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA2—lung cancer	1.69e-05	0.000205	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—STAT3—lung cancer	1.66e-05	0.000202	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NCOA3—lung cancer	1.66e-05	0.000202	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NRAS—lung cancer	1.66e-05	0.000201	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA1—lung cancer	1.64e-05	0.0002	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.63e-05	0.000198	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA1—lung cancer	1.63e-05	0.000198	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCC3—lung cancer	1.63e-05	0.000197	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ADCY1—lung cancer	1.61e-05	0.000196	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCG2—lung cancer	1.61e-05	0.000196	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCC3—lung cancer	1.61e-05	0.000196	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MAPK3—lung cancer	1.59e-05	0.000193	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HPGDS—lung cancer	1.58e-05	0.000192	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ENO2—lung cancer	1.58e-05	0.000192	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AKR1C1—lung cancer	1.58e-05	0.000191	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPP2R1B—lung cancer	1.57e-05	0.000191	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AKR1C1—lung cancer	1.56e-05	0.00019	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTEN—lung cancer	1.56e-05	0.000189	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.55e-05	0.000189	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MYC—lung cancer	1.54e-05	0.000188	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTT1—lung cancer	1.54e-05	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—UGT1A1—lung cancer	1.53e-05	0.000186	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GCLC—lung cancer	1.52e-05	0.000184	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2A6—lung cancer	1.52e-05	0.000184	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—UGT1A1—lung cancer	1.52e-05	0.000184	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.51e-05	0.000184	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—EGFR—lung cancer	1.51e-05	0.000183	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—EP300—lung cancer	1.48e-05	0.00018	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GNG11—lung cancer	1.47e-05	0.000179	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GNG11—lung cancer	1.46e-05	0.000178	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.45e-05	0.000177	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ENO1—lung cancer	1.44e-05	0.000175	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.43e-05	0.000174	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—KRAS—lung cancer	1.43e-05	0.000173	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.42e-05	0.000172	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALDOA—lung cancer	1.4e-05	0.00017	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALDOA—lung cancer	1.39e-05	0.000169	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NCOA3—lung cancer	1.36e-05	0.000165	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NCOA3—lung cancer	1.35e-05	0.000164	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.33e-05	0.000161	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ADCY1—lung cancer	1.33e-05	0.000161	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCG2—lung cancer	1.33e-05	0.000161	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ADCY1—lung cancer	1.31e-05	0.00016	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCG2—lung cancer	1.31e-05	0.00016	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CA—lung cancer	1.31e-05	0.000159	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HPGDS—lung cancer	1.3e-05	0.000158	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ENO2—lung cancer	1.3e-05	0.000158	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.29e-05	0.000157	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2E1—lung cancer	1.29e-05	0.000157	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HPGDS—lung cancer	1.29e-05	0.000157	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ENO2—lung cancer	1.29e-05	0.000157	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.28e-05	0.000156	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NQO1—lung cancer	1.28e-05	0.000155	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.26e-05	0.000153	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTT1—lung cancer	1.26e-05	0.000153	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTT1—lung cancer	1.25e-05	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.25e-05	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GCLC—lung cancer	1.25e-05	0.000151	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP2A6—lung cancer	1.25e-05	0.000151	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.24e-05	0.00015	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2A6—lung cancer	1.24e-05	0.00015	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GCLC—lung cancer	1.24e-05	0.00015	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.23e-05	0.000149	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HRAS—lung cancer	1.21e-05	0.000147	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ENO1—lung cancer	1.18e-05	0.000143	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ENO1—lung cancer	1.17e-05	0.000142	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.17e-05	0.000142	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6—lung cancer	1.16e-05	0.000141	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.15e-05	0.00014	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—STK11—lung cancer	1.15e-05	0.00014	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CA—lung cancer	1.1e-05	0.000133	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.08e-05	0.000131	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—AKT1—lung cancer	1.07e-05	0.00013	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTP1—lung cancer	1.06e-05	0.000129	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP2E1—lung cancer	1.06e-05	0.000129	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2E1—lung cancer	1.05e-05	0.000128	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NQO1—lung cancer	1.05e-05	0.000127	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NQO1—lung cancer	1.04e-05	0.000126	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CAT—lung cancer	1.04e-05	0.000126	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.03e-05	0.000125	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.02e-05	0.000124	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.01e-05	0.000122	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCB1—lung cancer	1.01e-05	0.000122	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TYMS—lung cancer	9.9e-06	0.00012	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTM1—lung cancer	9.78e-06	0.000119	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—STK11—lung cancer	9.45e-06	0.000115	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—STK11—lung cancer	9.37e-06	0.000114	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP1A1—lung cancer	9.28e-06	0.000113	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ERCC2—lung cancer	9.2e-06	0.000112	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—AKT1—lung cancer	8.97e-06	0.000109	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.79e-06	0.000107	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTP1—lung cancer	8.74e-06	0.000106	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTP1—lung cancer	8.67e-06	0.000105	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CAT—lung cancer	8.51e-06	0.000103	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CAT—lung cancer	8.43e-06	0.000102	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.38e-06	0.000102	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCB1—lung cancer	8.27e-06	0.0001	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCB1—lung cancer	8.2e-06	9.96e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TYMS—lung cancer	8.13e-06	9.87e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TYMS—lung cancer	8.06e-06	9.78e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTM1—lung cancer	8.03e-06	9.75e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTM1—lung cancer	7.96e-06	9.67e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOA1—lung cancer	7.96e-06	9.66e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.62e-06	9.25e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP1A1—lung cancer	7.61e-06	9.25e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ERCC2—lung cancer	7.55e-06	9.17e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP1A1—lung cancer	7.55e-06	9.17e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ERCC2—lung cancer	7.49e-06	9.09e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CG—lung cancer	7.27e-06	8.82e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—POMC—lung cancer	6.92e-06	8.4e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CREBBP—lung cancer	6.74e-06	8.18e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOA1—lung cancer	6.53e-06	7.93e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOA1—lung cancer	6.48e-06	7.86e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CD—lung cancer	6.39e-06	7.76e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALB—lung cancer	6.3e-06	7.66e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.2e-06	7.53e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CG—lung cancer	5.96e-06	7.24e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CG—lung cancer	5.91e-06	7.18e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—POMC—lung cancer	5.68e-06	6.89e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—POMC—lung cancer	5.63e-06	6.83e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CB—lung cancer	5.57e-06	6.76e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CREBBP—lung cancer	5.53e-06	6.72e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTGS2—lung cancer	5.52e-06	6.7e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CREBBP—lung cancer	5.48e-06	6.66e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CD—lung cancer	5.24e-06	6.37e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CD—lung cancer	5.2e-06	6.31e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALB—lung cancer	5.18e-06	6.29e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALB—lung cancer	5.13e-06	6.23e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTEN—lung cancer	4.81e-06	5.84e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—EP300—lung cancer	4.59e-06	5.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CB—lung cancer	4.57e-06	5.55e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CB—lung cancer	4.53e-06	5.5e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTGS2—lung cancer	4.53e-06	5.5e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTGS2—lung cancer	4.49e-06	5.45e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTEN—lung cancer	3.95e-06	4.8e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTEN—lung cancer	3.92e-06	4.75e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—EP300—lung cancer	3.77e-06	4.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—EP300—lung cancer	3.73e-06	4.53e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CA—lung cancer	3.39e-06	4.12e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CA—lung cancer	2.79e-06	3.38e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AKT1—lung cancer	2.77e-06	3.37e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CA—lung cancer	2.76e-06	3.35e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AKT1—lung cancer	2.28e-06	2.76e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AKT1—lung cancer	2.26e-06	2.74e-05	CbGpPWpGaD
